Cargando…
Structural and non-coding variants increase the diagnostic yield of clinical whole genome sequencing for rare diseases
BACKGROUND: Whole genome sequencing is increasingly being used for the diagnosis of patients with rare diseases. However, the diagnostic yields of many studies, particularly those conducted in a healthcare setting, are often disappointingly low, at 25–30%. This is in part because although entire gen...
Ejemplares similares
-
Targeted Next-Generation Sequencing of Plasma DNA from Cancer Patients: Factors Influencing Consistency with Tumour DNA and Prospective Investigation of Its Utility for Diagnosis
por: Kaisaki, Pamela J., et al.
Publicado: (2016) -
GREEN-DB: a framework for the annotation and prioritization of non-coding regulatory variants from whole-genome sequencing data
por: Giacopuzzi, Edoardo, et al.
Publicado: (2022) -
The complete costs of genome sequencing: a microcosting study in cancer and rare diseases from a single center in the United Kingdom
por: Schwarze, Katharina, et al.
Publicado: (2019) -
Clinically actionable mutation profiles in patients with cancer identified by whole-genome sequencing
por: Schuh, Anna, et al.
Publicado: (2018) -
Identification of Circulating Genomic and Metabolic Biomarkers in Intrahepatic Cholangiocarcinoma
por: Winter, Helen, et al.
Publicado: (2019)